Flu Vaccine Only 36 Percent Effective This Year
The U.S. Centers for Disease Control and Prevention (CDC) reported that the 2025–2026 influenza vaccine showed reduced effectiveness compared to previous seasons. Researchers linked the lower performance to the emergence of a new influenza A(H3N2) subclade that differed from the strain used to manufacture the vaccine.1 The CDC reported overall flu shot effectiveness at 36 […]
Fight for Justice After COVID-19 Vaccine Injury
When Chris was diagnosed with Guillain-Barre Syndrome following his AstraZeneca jab, he was promised a quick and simple compensation process. A thousand pages of paperwork and 498 days later, he’s facing a massive $2.4 million tax bill. If you would like to receive an e-mail notice of the most recent articles published in The Vaccine […]
They Acknowledge the Byproducts. Where Are the Data?
Pursuant to the order issued on March 16 in American Academy of Pediatrics et al. v. Kennedy et al., No. 1:25-cv-11916 (D. Mass.), the ACIP meeting previously scheduled for March 18-19 has been stayed until further notice. In light of this notice, I want to outline what should have been addressed at this meeting and […]
American College of Obstetricians and Gynecologists Withdraws from ACIP
The American College of Obstetricians and Gynecologists (ACOG) recently announced its withdrawal as a liaison organization from the U.S. Center for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP). The Association cited recent changes that have been made to the new ACIP committee, which the medical trade organization alleges undermines scientific integrity […]
Guinea-Bissau Hepatitis B Vaccine Trial in Newborns Sparks Ethics Debate
The World Health Organization (WHO) and some members of the U.S. Congress have raised ethical concerns about a U.S. Centers for Disease Control and Prevention (CDC) funded clinical trial examining the hepatitis B vaccine for newborns in Guinea-Bissau.1 The study would support a randomized controlled trial led by researchers at the University of Southern Denmark […]
Novartis Settles With Estate of Henrietta Lacks Over Stolen Cervical Cancer Cells
Novartis has reached a settlement with the estate of Henrietta Lacks over the use of the HeLa cell line, a line of human cells derived from tissue removed from Lacks during medical treatment for cervical cancer without her knowledge or consent. Terms of the settlement were not publicly disclosed.1 The settlement resolves claims that pharmaceutical […]